Skip to main content
Eyal Meiri, MD, Oncology, Atlanta, GA

EyalMeiriMD

Oncology Atlanta, GA

Gastrointestinal Cancer

Chief of Medical Oncology, Medical Oncologist

Dr. Meiri is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Meiri's full profile

Already have an account?

  • Office

    1800 Howell Mill Rd NW
    Ste 130
    Atlanta, GA 30318
    Phone+1 404-425-1777
    Fax+1 770-400-6841

Summary

  • Dr. Eyal Meiri is an oncologist in Newnan, GA and is affiliated with Cancer Treatment Centers of America Atlanta.

Education & Training

  • Henry Ford Health/Henry Ford Hospital
    Henry Ford Health/Henry Ford HospitalFellowship, Hematology and Medical Oncology, 1988
  • Detroit Medical Center/Wayne State University (Sinai Grace)
    Detroit Medical Center/Wayne State University (Sinai Grace)Residency, Internal Medicine, 1986
  • University of Toronto Faculty of Medicine
    University of Toronto Faculty of MedicineClass of 1983
  • University of Windsor
    University of WindsorBachelor's, Premedical Education, 1977 - 1979

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1987 - Present
  • FL State Medical License
    FL State Medical License 1995 - 2025
  • GA State Medical License
    GA State Medical License 2013 - 2025
  • MI State Medical License
    MI State Medical License 1984 - 1991
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Journal Articles

  • Efficacy of dronabinol alone and in combination with ondasetron versus ondasetron alone for delayed chemothrerapy-induced nausea and vomiting  
    Meiri E, Jhangiani H, Vredenburgh J, Barbato L, Carter F, Yang H, Baranowski V, Current Medical Research and Opinion, 1/1/2007
  • Rectal Non -Hodgkin's Lymphoma: a clinicopathologic study and review  
    Gottlieb CA, Meiri E, Maeda KM, Henry Ford Hospital Med J., 1/1/1990
  • Hypoglycemia after administration of Somatostatin Analogue (SMS 201-995) in Metastatic Carcinoid  
    Brunner JE, Kruger OR, Basha MA, Meiri E, Kaatz SS, Henry Ford Hospital Med J, 1/1/1989
  • Join now to see all

Abstracts/Posters

  • Salvage use of Y90 coated hepatic arterial beads in the treatment of liver predominant metastatic colorectal cancer: Cancer Treatment Centers of America Southeastern R...
    Eyal Meiri, John Florin Isac, John P. Geisler, Kelly J Manahan, Henry J. Krebs, Charles Fulp; Cancer Treatment Centers of America, Newnan, GA; Facultatea de Medicina s..., J Clin Oncol, St Josephs Hosp of Atlanta, Atlanta, GA, 2018; Cancer Treatment Centers of America Southeastern Regi, 1/1/2018
  • CARRIE: A Randomized, Double-blind, Placebo-controlled Phase 2 Study of Istiratumab (MM-141) plus Nab-Paclitaxel and Gemcitabine versus Nab-Paclitaxel and Gemcitabine ...
    Andrew H. Ko, Antonio Cubillo Gracian, Madappa Kundranda, Syed Farhan Zafar, Eyal Meiri, Johanna Bendell, Hana Alguel, Fernando Rivera Herrero, Eugene Ahn, David Watki..., LBA as ESMO, 1/1/2018
  • Identification of MEN1 mutation via Next Generation Sequencing in the Cancer Treatment Centers of America (CTCA) Database.
    Meiri E, Schwarzbach A, Dhillon N, Ewing A, Del Priore G, J Clin Oncol, 1/1/2015
  • Join now to see all

Lectures

  • Pembrolizumab (P) in patients (Pts) with colorectal cancer (CRC) with high tumor mutational burden (HTMB): Results from the Targeted Agent and Profiling Utilization Re... 
    ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/25/2020

Press Mentions

  • Filgrastim Biosimilars Comparable to Reference Drug
    Filgrastim Biosimilars Comparable to Reference DrugNovember 13th, 2018
  • 9 Colorectal Cancer Risk Factors You Can Control—and 7 You Can’t
    9 Colorectal Cancer Risk Factors You Can Control—and 7 You Can’tFebruary 28th, 2019
  • 19 Reasons Unexpected Weight Loss Could Be a Serious Problem
    19 Reasons Unexpected Weight Loss Could Be a Serious ProblemSeptember 14th, 2019

Committees

  • Member, Medical Executive Committee 2014 - 2018
  • Member, Cancer Committee 2013 - 2018
  • Member, Credentials Committee 2013 - 2018

Professional Memberships